| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |